JP2005213235A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005213235A5 JP2005213235A5 JP2004025267A JP2004025267A JP2005213235A5 JP 2005213235 A5 JP2005213235 A5 JP 2005213235A5 JP 2004025267 A JP2004025267 A JP 2004025267A JP 2004025267 A JP2004025267 A JP 2004025267A JP 2005213235 A5 JP2005213235 A5 JP 2005213235A5
- Authority
- JP
- Japan
- Prior art keywords
- dimethoxystyryl
- purine
- dihydro
- diethyl
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000013078 crystal Substances 0.000 claims 5
- -1 (E) -8- (3,4-Dimethoxystyryl) -1,3-diethyl-7-methyl-3,7-dihydro-1H-purine-2,6-dione pentahydrate Chemical compound 0.000 claims 3
- IQVRBWUUXZMOPW-PKNBQFBNSA-N istradefylline Chemical compound CN1C=2C(=O)N(CC)C(=O)N(CC)C=2N=C1\C=C\C1=CC=C(OC)C(OC)=C1 IQVRBWUUXZMOPW-PKNBQFBNSA-N 0.000 claims 3
- 239000004480 active ingredient Substances 0.000 claims 2
- 150000004687 hexahydrates Chemical class 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004025267A JP4731121B2 (ja) | 2004-02-02 | 2004-02-02 | キサンチン誘導体水和物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004025267A JP4731121B2 (ja) | 2004-02-02 | 2004-02-02 | キサンチン誘導体水和物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005213235A JP2005213235A (ja) | 2005-08-11 |
| JP2005213235A5 true JP2005213235A5 (enExample) | 2007-02-15 |
| JP4731121B2 JP4731121B2 (ja) | 2011-07-20 |
Family
ID=34907698
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004025267A Expired - Lifetime JP4731121B2 (ja) | 2004-02-02 | 2004-02-02 | キサンチン誘導体水和物 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4731121B2 (enExample) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ233646A (en) * | 1989-05-15 | 1991-10-25 | Bristol Myers Squibb Co | Water soluble, stable, sodium salts of 2',3'-dideoxy-2',3'-didehydro thymidine derivatives, 2',3'-dideoxy inosine and 2'-fluoro derivatives in the form of hydrates; pharmaceutical compositions |
| WO1997029108A1 (en) * | 1996-02-07 | 1997-08-14 | Smithkline Beecham Plc | Famciclovir monohydrate |
| WO1999030715A1 (en) * | 1997-12-15 | 1999-06-24 | Kyowa Hakko Kogyo Co., Ltd. | Preventives/remedies for sleep disturbance |
-
2004
- 2004-02-02 JP JP2004025267A patent/JP4731121B2/ja not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2711869C3 (ru) | Имидазопирролопиразиновые производные, полезные для лечения заболеваний, вызванных аномальной активностью протеинкиназ Jak1, Jak3 или Syk | |
| JP2007522220A5 (enExample) | ||
| NO2018016I1 (no) | Niraparib eller et farmasøytisk akseptabelt salt, stereoisomer eller tautomer derav, spesielt tosylatet eller et hydrat, spesielt tosylatmonohydratet | |
| EA200802198A1 (ru) | Полиморфы | |
| JP2006526031A5 (enExample) | ||
| JP2007269812A5 (enExample) | ||
| NO20050542L (no) | Fremgangsmate for fremstilling av kalsiumsaltet fra rosuvastatin | |
| UA96577C2 (en) | Hydrochlorides of 1-[(3-cyanopyridin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-aminopiperidin-1-yl)xanthine, their use as medicaments and pharmaceutical composition | |
| JP2011510079A5 (enExample) | ||
| EP1604989A8 (en) | DPP-IV inhibitors | |
| JP2009149903A5 (enExample) | ||
| JP2015520140A5 (enExample) | ||
| JP2007519721A5 (enExample) | ||
| EP2550965A3 (en) | Ceramide derivatives for treating polycystic kidney disease | |
| WO2006015860A3 (en) | Pyrazole derivatives for treating conditions mediated by activation of the adenosine a2b or a3 receptor | |
| EP2759540A3 (en) | Beta-3 receptor ligands and their use in therapy | |
| UY29857A1 (es) | Derivados de la 4-amino-quinazolina, su preparación y su aplicación en terapéutica. | |
| JP2006518752A5 (enExample) | ||
| JP2015520165A5 (enExample) | ||
| EP2305680A3 (en) | Novel salts of (1S,4R)-cis-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol | |
| RU2008128824A (ru) | НАТРИЕВАЯ СОЛЬ 2-ЭТИЛТИО-6-НИТРО-1,2,4-ТРИАЗОЛО[5,1-c]-1,2,4-ТРИАЗИН-7-ОНА ДИГИДРАТ | |
| JP2005213235A5 (enExample) | ||
| WO2006051314A8 (en) | Guanidine derivatives as inhibitors of ddah | |
| SMT201500012B (it) | 8-Cloro-3-pentil-3,7-diidro-1H-purin-2,6-dione 2-amine-2-(idrossimetil)-1,3-propandiolo anidrato peril trattamento di malattie | |
| RU2007123697A (ru) | Применение замещенных 7-арил(гетерил)-4,7-дигидро-1,2-4-триазоло[1,5-а]пиримидинов и их солей в качестве селективных противотуберкулезных препаратов, способ получения замещенных 7-арил(гетерил)-4,7-дигидро-1,2,4-триазоло[1,5-а]пиримидинов и фармацевтическая композиция на их основе |